Article Clinical Trials Microdosing 
The Cannigma
MARCH 7, 2021
This article was first published on Analytical Cannabis. People may not have to microdose psychedelics to feel their wellbeing benefits, according to a new study – they just have to believe they’ve microdosed them. Microdosing – regularly taking low doses of LSD or psilocybin – has gained popularity in recent years.
Otherside Farms
JANUARY 16, 2019
Microdosing, if you have not yet heard of it, is hotter than just any ordinary trend: Science proves THC and CBD safe, with very real benefits associated with consuming very low doses regularly, as opposed to massive doses all at once. People are microdosing psychedelics, vitamins, near everything for health purposes.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Canna Law Blog
JANUARY 22, 2020
The company is also running a phase IIb clinical trial of its patented formulation, COMP360, which we covered in a blog post back in 2018. In that post, I explained how the Food and Drug Administration (FDA) approval process works and why this trial is so interesting and important. Psilocybin!
The Joint Blog
NOVEMBER 15, 2021
While over the last few years, microdosing has become extremely popular, the act of microdosing has been recommended by experts for at least two decades. There are also many different substances that you can microdose, from psilocybin mushrooms to delta-8. In this article, we are going to cover microdose of legal substances.
Cannabis Law Report
MAY 10, 2023
However, a company may be in possession of the most healing psychedelic compound in the world, but unless they can prove it through the clinical trial process, their superior medicine will mean little. Yes, of course, it matters greatly who has the most effective medical psychedelic molecule in specific circumstances.
Cannabis Law Report
JUNE 19, 2022
For example, compounds such as psilocybin, mescaline, ibogaine, and LSD are being evaluated in clinical trials, but the compounds themselves are unpatentable because their existence is well documented in the prior art. Originally Published At Microdose. However, that does not mean that the path to patents is closed off.
Cannabis Law Report
NOVEMBER 24, 2019
The article argues for the implementation of nuanced risk assessment strategies for handling psychedelics in medicine, and predicts an expansion of psychedelic substances into mainstream medicine. Dr. Johnson recently spoke about microdosing and its affects on creativity. Participate in Our Studies. ANOREXIA NERVOSA. Upcoming Events.
Expert insights. Personalized for you.
136 
Let's personalize your content